What’s Propelling Sensus Healthcare, Inc. (SRTS) to Reach Record High?

May 6, 2018 - By Kenneth Lin

The stock of Sensus Healthcare, Inc. (NASDAQ:SRTS) reached all time high today, May, 6 and still has $7.07 target or 3.00 % above today’s $6.86 share price. This indicates more upside for the $93.08 million company. This technical setup was reported by Barchart.com. If the $7.07 PT is reached, the company will be worth $2.79 million more.
Trading stocks at an all time highs is usually a winning strategy. An all time high points to a stock which has the most positive fundamentals ever. Even thought the pullback rate is high, if correct risk management is utilized, investors can trade very well such events.

The stock increased 5.54% or $0.36 during the last trading session, reaching $6.86. About 21,815 shares traded or 106.78% up from the average. Sensus Healthcare, Inc. (NASDAQ:SRTS) has risen 32.96% since May 6, 2017 and is uptrending. It has outperformed by 21.41% the S&P500.

More recent Sensus Healthcare, Inc. (NASDAQ:SRTS) news were published by: Prnewswire.com which released: “Sensus Healthcare Reports First Quarter Financial Results Featuring 37% Revenue Growth” on May 03, 2018. Also Prnewswire.com published the news titled: “Sensus Healthcare Expands International Business to Meet Rising Patient Demand for Non-Invasive Skin Cancer and …” on April 19, 2018. Streetinsider.com‘s news article titled: “Form 8-K Sensus Healthcare, Inc. For: May 03” with publication date: May 03, 2018 was also an interesting one.

Sensus Healthcare, Inc. manufactures and markets superficial radiation therapy devices to healthcare providers worldwide. The company has market cap of $93.08 million. It offers SRT-100, a photon x-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameter. It currently has negative earnings. The firm also provides Sentinel service program, which offers its clients protection for their SRT-100 and SRT-100 Vision systems.

Sensus Healthcare, Inc. (NASDAQ:SRTS) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: